Announcements Trials
Browse Landscape

Phase

Phase 1 1

Status

Completed 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Thoracic 1Head & Neck 1

Conditions

Head and Neck Neoplasms 4Lung Neoplasms 3Carcinoma, Non-Small-Cell Lung 3Uterine Cervical Neoplasms 2Urinary Bladder Neoplasms 2Tobacco Use Disorder 2Stomach Neoplasms 2Squamous Cell Carcinoma of Head and Neck 2Small Cell Lung Carcinoma 2Pancreatic Neoplasms 2Oropharyngeal Neoplasms 2Nasopharyngeal Neoplasms 2Mouth Neoplasms 2Liver Neoplasms 2Leukemia, Myeloid, Acute 2Leukemia 2Laryngeal Neoplasms 2Kidney Neoplasms 2Hypopharyngeal Neoplasms 2Esophageal Neoplasms 2Carcinoma, Renal Cell 2Carcinoma, Hepatocellular 2cyclopia sequence 1Smoking 1Nasopharyngeal Carcinoma 1Laryngeal Diseases 1Carcinoma 1

Interventions

Surveys and Questionnaires 2Radiotherapy 2olaparib 1Varenicline 1Interviews as Topic 1Chemoradiotherapy 1Cetuximab 1Bupropion 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Smoking × Bupropion × Head & Neck × Clear all
NCT02048917 2020-01-29

Optimization of Smoking Cessation Strategies Concurrent With Treatment of Tobacco Related Malignancies

University of Kentucky

Phase 1 Completed
93 enrolled
Head & NeckThoracic

Head and Neck Neoplasms, Lung Neoplasms, Smoking

Data powered by HemOnc (CC BY 4.0) Colophon âš¡